Atlas Trials

Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer

Clinical trial NCT01074138 · COMPLETED

Trial details

NCT number
NCT01074138
Sponsor
Athenex, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bone-Metastatic, Castration-Resistant Prostate Cancer
Start date
2010-02-01
Primary completion
2012-06-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.